Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 5
Original Research
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,682 | Dovepress* | 10,982+ | 1,847 | 12,829 | |
| PubMed Central* | 700 | 237 | 937 | ||
| Totals | 11,682 | 2,084 | 13,766 | ||
|
*Since 17 June 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 0 | 3 |
View citations on PubMed Central and Google Scholar